GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment.
Cell Metab. 2022 Aug 2;34(8):1151-1167.e7. doi: 10.1016/j.cmet.2022.06.010. Epub 2022 Jul 14.
Cell Metab. 2022.
PMID: 35839757